Avalo Therapeutics, Inc.
Avalo Therapeutics, Inc.（AVTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
avtx · 股价预测 · 9 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$60.00
Consensus
$47.14
+262.6% upside
Low
$34.00
Median: $48 · Last Close: $13.00
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$47.14
262.6% upside
High Target
$60
361.5%
Low Target
$34
161.5%
Current Price
$13.00
as of today
Based on analyst price targets, the AVTX stock price prediction for the next 12 months ranges from $34 to $60. The consensus AVTX price forecast of $47.14 implies 262.6% upside from the current price of $13.00.
短期股价预测
Low Activity算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.35 | ↓ 5.00% |
1-day model range: $11.88–$12.82. Peak: $12.82 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | -49.6% |
| 2028 | — | -62.1% |
| 2029 | — | -66.8% |
| 2030 | — | -68.8% |
| 2031 | — | -69.8% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · AVTX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-14 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-14 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-14 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-05-14 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-11 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-05-06 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-06 | BTIG | Maintains | Buy→Buy |
| 2026-05-06 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2026-04-13 | BTIG | Maintains | Buy→Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Avalo Therapeutics, Inc. (AVTX) stock. Of the recent 23 rating actions, 1 were upgrades and 4 were downgrades. 9 analysts currently cover AVTX.
分析师推荐趋势
AVTX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 8 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1M
↑ 7102.5% YoY
Revenue Next Year
$1M
↑ 0.0% YoY
EPS This Year
$-3.16
EPS Next Year
$-3.15
↓ 0.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast AVTX EPS of $-3.16 for the current fiscal year, based on estimates from 8 analysts. The AVTX revenue forecast is $1M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
AVTX 股价预测由两类独立数据源支撑：来自 9 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。AVTX 的共识目标价为 $47.14（+262.6% 上行空间），分析师共识为 Buy。
AVTX 的短期预测（明日）为 $12.35（-5.00%）。 AVTX 对 2030 年的预测区间为 $3–$5。
Avalo Therapeutics, Inc. 在 NASDAQ 上市，代码 AVTX。AVTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 78% 对应 Buy 共识。
常见问题
AVTX 预测 · 8 个问题根据 9 位华尔街分析师，AVTX 的 12 个月平均目标价为 $47.14，最高 $60.00、最低 $34.00。若有图表，中位目标价可在上方查看。相对当前价 $13.00，隐含约 +262.6% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.